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(ASCs) induced to differentiate into adipocytes in vitro. Gene expression was assessed on days 1, 7, 14 and 21
post-induction and genes differentially expressed numbered 128, 218, 253 and 240 respectively. Up-regulated
genes were associated with blood vessel development, leukocyte migration, as well as tumor growth, invasion
and metastasis. They also shared common pathways with certain obesity-related pathophysiological conditions.
Down-regulated genes were enriched for immune response processes. KLF15, LMO3, FOXO1 and ZBTB16 tran-
scription factors were up-regulated throughout the differentiation process. CEBPA, PPARG, ZNF117, MLXIPL,
MMP3 and RORBwere up-regulated only on days 14 and 21, which coincide with the maturation of adipocytes
and could possibly serve as candidates for controlling fat accumulation and the size ofmature adipocytes. In sum-
mary, we have identiﬁed genes that were up-regulated only on days 1 and 7 or days 14 and 21 that could serve as
potential early and late-stage differentiation markers.
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Obesity1. Background
Adipose tissue plays an important role in energy homeostasis
and the regulation of insulin sensitivity in the muscle, and is an endo-
crine organ that secretes factors that regulate energy metabolism
(Spiegelman and Flier, 2001; Rosen and Spiegelman, 2006). White adi-
pose tissue (WAT) constitutes the predominant type of fat present in
adult humans and is mainly involved in energy storage, while brown
adipose tissue (BAT) which has thermogenic properties is abundant in
newborns with small depots located in the supraclavicular regions and
neck in adults (Merklin, 1974; Cypess et al., 2009). A third class of adi-
pose tissue known as “beige” or “brite” adipose tissue is found within
certain WAT depots and has similar thermogenic functions to those of
BAT (Petrovic et al., 2010; Schulz et al., 2011; Cinti, 2012). Excessive ac-
cumulation ofWAT, which is constituted of adipocytes, results in obesi-
ty. Obesity is a major risk factor for the development of type 2 diabetes
mellitus (T2DM), cancer and cardiovascular disease (CVD) (Stephens,Molecular Medicine, SAMRC
ept. of Immunology, Faculty of
h Africa.
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ael.Pepper@up.ac.za
. This is an open access article under2012). Recent WHO reports have stated that in 2012, of all new cancer
cases, half a million were due to overweight and obesity with the pro-
portion of obesity-related cancers being higher in women than in men
(WHO, 2014). This trend was reported to be higher in richer countries
with a similar trend being observed in some developing countries. Fur-
thermore, the number of overweight and obesity related diseases is set
to increase in virtually every country in the world, thus making it an
issue of international public health concern.
The regulation of many genes such as the retinoblastoma gene and
the E2F family of transcription factors has been reported to occur in a
differentiation dependent manner during adipogenic differentiation in
3T3-L1 cells (Richon et al., 1997). Other transcription factors (TFs) like
peroxisome proliferator activated receptor-gamma (PPARG) and
CCAAT-enhancer binding protein-alpha (CEBPA) are activated during
adipogenesis, as well asmany other genes involved in lipidmetabolism,
which altogether play a role in the proper functioning of the mature
adipocyte (Darlington et al., 1998; Rosen et al., 2000; MacDougald
and Lane, 1995). To better understand the scale of gene expression
changes that occur during the formation of mature adipocytes from
preadipocytes, we compared and characterised the transcriptome pro-
ﬁle of stromal cells derived from human adipose tissue, otherwise
known as adipose-derived stromal cells (ASCs), undergoing adipocyte
differentiation in vitro on days 1, 7, 14 and 21 (which represent the
early to late stage processes of adipogenesis).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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pression in the 3T3-L1 preadipocyte cell line during adipogenesis and in
adipocytes from mouse both in vitro and in vivo (Guo and Liao, 2000;
Soukas et al., 2001). This technique was systematically employed to
study gene expression in human ASCs during adipogenic differentiation
over a 21 day period to identify genes that are important in driving ad-
ipogenesis in vitro. The results could contribute to our understanding of
adipogenesis, related biological processes, and the development of obe-
sity and its co-morbidities. These genes could potentially bemanipulat-
ed to control adipogenesis at different stages, with an overall goal of
reducing excess accumulation of fat. This may open up new avenues
for the control of adipogenesis to combat obesity and its related
diseases.
2. Material andmethods
2.1. Ethics statement
All subjects participating in this study provided written informed
consent and the study was approved by the Faculty of Health Sciences
Research and Ethics committee, University of Pretoria, South Africa
(ethics reference no.: 421/2013). This study was conducted according
to the Declaration of Helsinki.
2.2. ASC culture, immunophenotypic characterisation and induction of
adipogenic differentiation
ASCs were isolated from human abdominal subcutaneous adipose
tissue from four individual donors undergoing liposuction as previously
described (Zuk et al., 2001), with somemodiﬁcations. Samples were la-
belled A, B, C and D (A; female of age 19, B; male of age 32, C; female of
age 28 and D; female of age 20). Each individual constituted one of the
four biological replicates referred to herein. Cells fromdonors A, B, C and
D were cultured in complete culture medium consisting of α-MEM
(GIBCO, Life Technologies™, New York, USA) supplemented with
10% foetal bovine serum (FBS; Biochrom) and 2% (v/v) penicillin
[10,000 U/mL]–streptomycin [10,000 μg/mL] (p/s; GIBCO, Life
Technologies™, New York, USA) in 80 cm2 culture ﬂasks (NUNC™,
Roskilde Site, Kamstrupvej, Denmark) at 37 °C in a 5% CO2 incubator
(Thermo Forma CO2 water jacketed incubator, 3111TF). The cells used
in this study had been cryopreserved and were thawed just prior to
use. When the cultures reached 80% conﬂuence, they were washed
twice with 4 mL PBS containing 2% (v/v) p/s and detached from
the bottom of culture ﬂask by adding 3 mL trypsin (GIBCO, Life
Technologies™, New York, USA) followed by incubation at 37 °C in 5%
CO2 for about 7–10min to ensure that the cells were dislodged. Trypsin
was neutralised by adding equal amounts of complete medium and the
suspension was centrifuged at 184 g for 5 min to pellet the cells.
Immunophenotypic characterisation had previously been performed
using ﬂow cytometry on fresh cells at each passage and on frozen
cells prior to adipogenic induction. Brieﬂy, each sample was incubated
for 15 min at 37 °C in the dark with a panel of monoclonal anti-
bodies (mouse anti-human CD73-APC (BioLegend, San Diego, USA)/-
FITC (eBioscience, San Diego, USA), CD105-PE, CD90-FITC/-PC5, CD34-
PC7/-ECD/-PE/-FITC, and CD45-PC5/-PC7/-ECD (Beckman Coulter,
Miami, USA). Data was acquired on either a FC500 MCL or Gallios
(10 colours, 3 lasers) ﬂow cytometer (Beckman Coulter, Miami, USA).
All data sets were analysed using Kaluza Flow Cytometry analysis soft-
ware 1.2 (BeckmanCoulter,Miami, USA). For adipogenic differentiation,
cells from donors A, B, C and D at passages 15, 6, 12 and 12 respectively
were seeded at a density of 5000 cells/cm2 in complete culture medium
and grown to conﬂuence. The cell cultures were washed twice with
4 mL PBS containing 2% (v/v) p/s and differentiation was induced by
adding adipogenic induction cocktail to the cell cultures as previously
described (Ogawa et al., 2004), with slight modiﬁcations, while control
cultures (non-induced) received only complete culture medium.The adipogenic induction cocktail used consisted of Dulbecco's
Modiﬁed Eagle's Medium (GIBCO, Life Technologies™, New York,
USA) supplemented with 10% FBS, 2% (v/v) p/s, insulin (10 μg/mL),
dexamethasone (1 μM), isobutylmethylxanthine (0.5 M) and indo-
methacin (200 μM). Differentiation was allowed to proceed over a
21 day period and cells from both adipogenic induced cultures and
their respective controls were harvested on days 1, 7, 14 and 21 (as il-
lustrated in the study design in Supplementary Fig. S1) and used for
RNA isolation. To conﬁrm lipid droplet formation during the process of
adipogenesis, both the non-induced and induced cells were stained
with 4′, 6-diamino-2-phenylindole, dihydrochloride [2.5 μg/mL] (DAPI,
Life Technologies, Oregon, USA) and Nile Red [50 ng/mL] (Life Technol-
ogies, Oregon, USA). Images were captured at 20× magniﬁcation using
anAxioVert A1 inverted ﬂuorescencemicroscope (Carl Zeiss, Gottingen,
Germany) equipped with an AxioCam Cm1 camera (Carl Zeiss,
Gottingen, Germany).
2.3. RNA isolation and RT-qPCR
Total cellular RNAwas isolated fromnon-treated and treated cells on
days 1, 7, 14 and 21 following adipogenic induction using the RNeasy
Minikit (Qiagen, Hilden, Germany) according to the manufacturer's in-
structions. Prior to the generation of cDNA, the quality and integrity of
the RNA were assessed using the Agilent Tape station 2000 and
corresponding kit (Agilent Technologies, California, USA) according
to the manufacturer's instructions. cDNA was synthesised using
the iScript™ Reverse Transcription Supermix (Bio-Rad Laboratories,
Inc., Hercules, CA, USA). PCR reactions were performed in 10 μL
using the LightCycler® 480 SYBR Green I Master Mix (Roche, Basel,
Switzerland), with primer concentrations of 400 nM and a cDNA con-
centration of 20 ng/μL. RT-qPCR was performed on a LightCycler® 480
II (Roche, Basel, Switzerland) under the following conditions: denatur-
ation at 95 °C for 5 min and 45 cycles of ampliﬁcation at 95 °C for 30 s,
62 °C for 30 s, and 72 °C for 30 s. After ampliﬁcation a melt curve was
performed at 95 °C for 30 s and 40 °C for 30 s, and ramped at 0.1 °C/s.
The primers (IDT, Coralville, IA, USA) and their sequences for the
genes of interest and the reference genes (internal controls) used are
shown in Supplementary Table S1.
2.4. Microarray gene expression experiment
RNA (200 ng) isolated on D1, D7, D14 and D21 from non-induced
and adipogenic induced ASC cultures from donors A, B, C, and D at
passages 15, 6, 12 and 12 respectively was used for ﬁrst and second
strand cDNA syntheses. This was followed by the synthesis and ampliﬁ-
cation of complementary RNA (cRNA) by in vitro transcription using an
Affymetrix GeneChip® WT PLUS Reagent Kit according to the
manufacturer's protocol. Magnetic puriﬁcation beads supplied with
the kit were used to purify ampliﬁed cRNA product and 15 μg of the pu-
riﬁed cRNA productwas used to synthesise second cycle single stranded
cDNA (ss-cDNA). This was followed by another puriﬁcation step using
magnetic puriﬁcation beads as described in themanufacturer's protocol.
Puriﬁed ss-cDNA (5.5 μg) was fragmented, labelled and used to prepare
a hybridisation cocktail as described in the Affymetrix GeneChip® WT
PLUS Reagent Kit manual. Hybridisation was performed using the
Affymetrix GeneChip® Hybridisation Wash and Stain Kit as described
in the manufacturer's protocol. Hybridisation cocktail was hybridised
to Affymetrix GeneChip® Human Gene 2.0 ST arrays. The array was
placed in an Affymetrix GeneChip® Hybridisation Oven-645 rotating
at 60 rpmat 45 °C for 17 h, afterwhich the chipwaswashed and stained
in an Affymetrix GeneChip® Fluidics Station-450Dx before scanning
using an Affymetrix GeneChip® Scanner-7G. The output Affymetrix
CEL ﬁles which have intensity values for all probes present on the
scanned chips were used for further analysis. The Robust Multiarray
Analysis algorithm (Irizarry et al., 2003) in Affymetrix Expression
Console™was used to perform background correction, summarisation,
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ﬁles, giving the resultant output in a CHP ﬁle format. Affymetrix Tran-
scription Analysis Console™ was used to calculate fold change of each
probe set or transcript cluster identiﬁer number and mapped onto the
corresponding gene. We applied very stringent criteria of fold-change
of ≥4 and ≤−4 with p b 0.05 and FDR b 0.5 for selecting differentially
expressed genes which were used for further analysis. The fold change
value of each gene represents howmuch the expression of that particu-
lar gene has changed from the control to the induced cells based on the
signal measured. The microarray data ﬁles of this study have been de-
posited in NCBI GEO (Gene Expression Omnibus) with assigned GEO ac-
cession number GSE77532.
2.5. Bioinformatics analyses
The principal component analysis (PCA) tool provided by Affymetrix
Expression Console™ softwarewas used to asses relatedness of samples
from all four donors used in this study based on the microarray data.
Considering the genes from microarray data as variables, PCA creates a
cluster of principal components which best explains the experimental
response of each sample based on the genes' features. The PCA plot
has three components namely PCA1, PCA2 and PCA3. Clustering of sam-
ples along PCA1 axis occurs such that it retains as much variation of the
data as possiblemaking it themost important component on a PCAplot.
PCA2 captures the majority of the variation not captured in PCA1 while
PCA3 captures the majority of the variation not captured in PCA2. The
AmiGO 2 Gene ontology tool provided by BIOBASE TRANSFAC®
(Matys et al., 2006) license software was used to classify differentially
expressed genes into biological processes that they were enriched for.
STRING v10 (Szklarczyk et al., 2015) was used to determine known
and predicted functional interactions among genes at the protein level
and also to predict other functional proteins interacting with these
gene products in Homo sapiens. Molecular network and pathway analy-
sis were performed using QIAGEN's Ingenuity® Pathway Analysis
(IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity). IPA uses
computational algorithms to identify canonical pathways andmolecular
interaction networks that are enriched for the input gene set in the In-
genuity Pathways Knowledge Base. It then uses the Fisher's exact test
to test for the signiﬁcance of each identiﬁed pathway and the interac-
tion network linked to the input gene compared to the whole Ingenuity
Pathways Knowledge Base.
3. Results anddiscussion
3.1. ASC characterisation
ASCs were isolated from four individual donors. These cells were
positive for CD 73, 90 and 105 and were negative for CD 34 and 45 as
shown by Durandt et al. (2016). The induced ASCs successfully
underwent adipogenesis over the 21 day induction period, while the
non-induced ASCswere devoid of characteristic adipogenic lipid droplet
formation (Fig. 1) (Durandt et al., 2016). Intracellular accumulation of
lipid droplets is a key characteristic of adipocyte differentiation and
quantiﬁcation of intracellular lipid content by ﬂow cytometry (Nile
Red staining) as described in Durandt et al. (2016)) showed a gradual
increase in the percentage of cells with increased intracellular lipid con-
tent over the 21-day induction period: 2.80 ± 4.42% 24 h post-induc-
tion, 7.50 ± 9.08% at 7 days post-induction, 15.18 ± 3.70% at 14 days
post-induction and 20.48±13.49% at 21 days post-induction. However,
since this study did not investigate the effect of cell passage number on
the differentiation potential of ASCs, it is possible that the relatively low
differentiation rates observed here could have been due to the relatively
late passage number of some of the cells used as it has been shown that
ASC adipogenic potential decreases with increased passage number
(Safwani et al., 2014).3.2. Differentially expressed genes during adipogenesis
Gene expression was studied over a 21 day period in a total of 32
samples from four biological replicates each consisting of non-induced
and induced ASC cultures using Affymetrix GeneChip® Human Gene
2.0 ST arrays containing a 48,226 probe set. Microarray analysis re-
vealed that 61, 124, 138 and 149 genes were signiﬁcantly up-
regulated while 67, 94, 115 and 91 genes were signiﬁcantly down-
regulated on days 1, 7, 14 and 21 respectively. A complete list of all
genes that were differentially expressed during the differentiation pro-
cess is provided in the supplementary data (Tables S2_1–S2_4).
PCA plots showed two large independent clusters along principal
component 1 axis (PCA1) (Fig. S2). The ﬁrst cluster which lies close to
the origin of the PCA1 axis consists of all the control samples from all
four donors, while the other cluster which lies further up the PCA1
axis consists of all induced samples from all four donors. Furthermore,
D1 induced samples for all four donors formed a minor cluster which
is closer to all the induced samples on D7–D21 in the same plane
(PCA1). The clustering of all induced samples away from all the control
samples conﬁrms consistency in gene expression duringASC adipogenic
differentiation for all four donors (Fig. S2).
3.3. Gene expression proﬁle of ASCs during adipogenesis
Induction of adipogenesis in ASCs resulted in 61 genes being signif-
icantly up-regulated within 24 h. Of the 61 genes, 32 (AOX1, CHRDL1,
CIDEC, CNR1, CPM, CRISPLD2, EDNRB, FASN, FOXO1, GALNT15, GLUL,
GREB1L, HSD11B1, KLF15, LMO3, MAOA, METTL7A, MT1F, MT1M, MT1X,
NEFL, NID1, NRCAM, PDK4, PRUNE2, RASD1, RASSF4, RGCC, SAMHD1,
SLC19A2, WNT5A and ZBTB16) remained signiﬁcantly up-regulated
throughout the 21 day differentiation period. The constant up-
regulation of these genes suggests that they play an important role in
mediating adipogenic differentiation in ASCs.
Four of the 32 consistently up-regulated genes (KLF15, LMO3, FOXO1
and ZBTB16) encode TFs which are likely to be important in driving the
adipogenic differentiation process by regulating the expression of
downstream target genes. Silencing of the LMO3 TF has been shown
to suppress adipogenesis (Lindroos et al., 2013), which is in line with
its identiﬁcation in our study as an important TF in adipogenesis and
its constant up-regulation during this process. ZBTB16, reported to
have a role in brown adipocyte bioenegertics (Plaisier et al., 2012), re-
mains to be characterised functionally with respect to its precise role
in adipogenesis. FOXO1 and KLF15 have been shown to play crucial
roles in adipocyte differentiation (Munekata and Sakamoto, 2009; Wu
andWang, 2013). Consequently, the identiﬁcation of these 4 important
TFs validates our study methodology which is aimed at identifying im-
portant genes with functional roles during adipogenesis. RASSF4, an on-
cogene that has been shown to promote cell cycle progression,
senescence evasion, and tumorigenesis in alveolar rhabdomyosarcoma
(Crose et al., 2014), with no previously reported function in adipogene-
sis, was found to be expressed in this study. However, this observation
requires further investigation to determine its role in adipogenesis
and other pathophysiological disorders such as obesity related cancer.
A unique gene signature pattern was identiﬁed for ASCs at different
time points during the differentiation process as shown in Fig. 2. Genes
that were expressed speciﬁcally on different days may play a pivotal
role at that particular time point. However, their exact role remains to
be functionally determined in vivo. The gene expression proﬁle report-
ed in this study is likely to be speciﬁc to the differentiation and accumu-
lation of human adipocytes in the subcutaneous fat depot. This
expression proﬁle would most likely differ from ASCs isolated from
other fat depots due to the inherent properties of depot-speciﬁc ASCs,
whichmay contribute to the overall depot-speciﬁc changes in fat tissue
that occur at different rates and with increasing age (Kirkland et al.,
2002; Cartwright et al., 2007). In addition, subcutaneously derived
ASCs have been shown to exhibit higher levels of lipid accumulation,
Fig. 1. Fluorescence microscopy images of ASCs induced to differentiate into adipocytes. Images were captured 24 h post-induction (A & E), 7 days post-induction (B & F), 14 days post-
induction (C & G) and 21 days post-induction (D &H). A–D: Representative images of ASCs not induced to undergo adipogenesis (controls). E–H: Representative images of ASCs that were
induced to differentiate into adipocytes. All images were captured at 20× magniﬁcation.
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and less TNF-α induced apoptosis than ASCs from other fat depots
(Cartwright et al., 2007).
STRING v10 analysis of the four TFs (KLF15, LMO3, FOXO1 and
ZBTB16) thatwere signiﬁcantly up-regulated throughout the differenti-
ation process identiﬁed sirtuin 1 (SIRT1), v-akt murine thymoma viral
oncogene homolog 1 (AKT1), histone deacetylase 1 (HDAC1) andnucle-
ar receptor co-repressor 2 (NCOR2) as functional partners that strongly
interact with KLF15, FOXO1 and ZBTB16 but not with LMO3 (Fig. 3,
panel A), thereby suggesting their functional role in adipogenesis.
SIRT1 has been show to promote lipolysis and loss of fat in differentiat-
ing 3T3-L1 adipocytes (Picard et al., 2004). RNA interference of
protein kinase B/Akt 1 has been shown to block adipogenic differentia-
tion in 3T3-L1 preadipocytes (Xu and Liao, 2004). Conversely, HDAC1
knock-down has been shown to promote adipogenesis, while itsoverexpression in 3T3-L1 preadipocyte cell lines attenuates the process
(Yoo et al., 2006). NCOR2 inhibits adipogenic differentiation by binding
to PPARG and represses the expression of PPARG target genes (Schmitt
et al., 2011). The identiﬁcation of genes involved in adipogenesis
through this methodology suggests that they play a fundamental role
in adipogenesis through their interactions, which should therefore be
studied further in appropriate models in vivo.
Six genes (CEBPA, ZNF117, MLXIPL, MMP3, RORB, PPARG) encoding
for TFs were identiﬁed to be signiﬁcantly up-regulated from D14 on-
wards during the differentiation process (Fig. 2). CEBPA and PPARG
have been studied extensively and have been demonstrated to play cru-
cial roles in determining adipocyte fate (Lefterova and Lazar, 2009).
Identiﬁcation ofMLXIPL, ZNF117,MMP3 and RORB together with CEBPA
and PPARG suggests that they may also play a crucial role in terminal
differentiation and maturation, and proper functioning of mature
Fig. 2. Gene expression on different days during adipogenesis in ASCs. Transcription factors expressed on the different days (D1, D7, D14 and D21) are shown in the top half of the panel
while unique gene signatures at the same time points are shown in the lower half of the panel.
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their downstream target genes. The early expression (D1 and D7) of
the circadian core clock gene PER1 and the late expression of RORB
(D14 and D21) with its role in circadian behaviour (André et al.,
1998)suggest that PER1 and RORB are two important elements
controlling the internal clock mechanism in adipogenesis/adipocyte
functioning in response to anticipated environmental changes such as
circulating levels of insulin, adrenaline, glucose, fatty acids and triglyc-
erides. PER1 and RORB could therefore serve as potential targets for
correcting disorders arising from an abnormal circadian rhythm inFig. 3. STRING v10 prediction of functional interacting partners of TF gene product during ad
adipogenesis while panel B represents the functional interaction of TFs up-regulated on D14 anadipose tissue functioning. MLXIPL and ZNF117 were identiﬁed in this
study but have no previously reported role in adipogenesis. Based on
our gene expression studies, we therefore propose that MLXIPL and
ZNF117 may play a functional role in adipocyte differentiation which
will require validation in vivo.
Based on STRING v10 analysis, CEBPA, MMP3, RORB and PPARG but
not MLXIPL and ZNF117 TFs strongly interact with each other at the
protein level with peroxisome proliferator-activated receptor gamma,
coactivator 1 alpha (PPARGC1A), nuclear receptor coactivator 1
(NCOA1),mediator complex subunit 1 (MED1) and E1Abinding proteinipogenesis. Panel A represents the functional interaction of TFs up-regulated throughout
d D21 only with new functional partners.
Fig. 4.Multi-step process of adipogenesis in ASCs. This gene expression study reveals that
adipogenesis in ASCs is a multi-step process with lipid and fatty acid cellular and
biochemical processes dominating one week post-adipogenic induction followed by
terminal differentiation and maturation of adipocytes.
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these TFs (Fig. 3, panel B). This interaction suggests their involvement
in common biological functions/processes, in this case, terminal differ-
entiation, maturation, size determination and fatty acid metabolism in
adipocytes. This makes them attractive targets for controlling these
and other functions related to mature adipocytes.
3.4. Functional analysis by gene ontology classiﬁcation reveals that adipo-
genesis is associated with other important biological processes
Functional classiﬁcation of differentially expressed genes (DEGs) by
gene ontology (GO) enrichment revealed that gene sets that were sig-
niﬁcantly up-regulated on different days (D1–D21) duringASC differen-
tiation were signiﬁcantly enriched for biological processes such as the
response to glucocorticoids (ACACB, ADIPOQ, GLUL, GPD1,MAOA, PDK4,
RASD1 and TSC22D3), the response to insulin (ACACB, ADIPOQ, CIDE-3,
FOXO1, INHBB, KLF15, LIPE, LPL, PDK4, PLIN4, PNPLA3 and RBP4), and
the fatty acid metabolic process (ABCD2, ACSF2, ACSL1, ACSL5, ADIPOQ,
FABP4, FASN, GPAM, LIPE, LPL and PDK4). Down-regulated genes from
D1 to 21 were signiﬁcantly enriched for GO biological process such as
collagen ﬁbril organisation (GO:0030199). Furthermore, C3, CFB,
COLEC12, CXCL12, DPP4, ICAM1, IFI30, IL6, LOXL4, PDCD1LG2, IER3 and
SEMA7A which are associated with immune responses (GO:0006955)
and with positive regulation of immunoglobulin secretion
(GO:0051024) were signiﬁcantly enriched in down-regulated gene
sets. DRAM1, ABCA9,MET, CXCL12, IL6, DOK5, DPP4, NT5E, IFI30 and CFB
which are associated with positive regulation of neutrophil differentia-
tion, monocyte differentiation, positive regulation of T-cell proliferation
and activation, B-cell activation and regulation of antigen processing
and presentation of peptide antigens via MHC class II GO biological pro-
cesses were also signiﬁcantly enriched in down-regulated gene sets
during ASC differentiation. This suggests that adipogenesis is associated
with down-regulation of immune function.
Genes that were associated with GO biological processes such as
vasculogenesis and angiogenesis (EDNRB, CHRDL1, EDNRB, RGCC,
ANGPT1, ANGPTL1, PDE3B, DAMTS15, ANGPTL4, FOXO1, PRL, F3, HAS2,
MCAM, CALCRL, COMP, HP and FZD4) and neural development (NEFL,
MME, APOD, FAM134B, MTIF, MTIX and SLC19A3) were signiﬁcantly
enriched in up-regulated gene sets during ASC differentiation. This sug-
gests that adipogenesis is associatedwith neural and blood vessel devel-
opment and supports previous ﬁndings by other authors (Billon et al.,
2010).
3.5. Adipogenesis revealed as a concurrent multi-step process
Based on GO biological process terms searched, genes that were sig-
niﬁcantly up-regulated up to D7 of adipogenic induction were enriched
for lipid and fatty acid biosynthesis, metabolism, transport and storage
processes. These biological processes increased exponentially from D1
to D14 before levelling out from D14 to D21 (Fig. 4). Signiﬁcant up-
regulation of CEBPA, GPD1 and PPARG, which are actively involved in
the positive regulation of fat cell differentiation, was observed from
D14 onwards, suggesting that adipogenic differentiation occurs in
ASCs after D7 of induction as shown in Fig. 4. Lipid and fatty acid forma-
tion as well as fat cell differentiation occur simultaneously during this
time period (D7–D14) and level out from D14 to 21 (Fig. 4). This sug-
gests that terminal differentiation of ASCs from D14 onwards is accom-
panied by the maturation of functional adipocytes. Conversely, GO
terms enriched for cell proliferation remain fairly constant throughout
the differentiation process. From our gene expression studies, adipo-
genesis in ASCs could be described as follows; adipogenic induction of
preadipocytes causes an initial increase in lipid and fatty acid biological
processes in the cell within one week of induction (D1–D7). This pro-
cess increases exponentially (D1–D14) and occurs simultaneously
with the differentiation of preadipocytes into adipocytes (post-D7 of in-
duction), which is then followed by terminal differentiation andmaturation of adipocytes (D14–21). The initial increase in lipid and
fatty acid metabolism, biosynthesis, transport and storage processes
may be very important in that it prepares the cells to differentiate into
adipocytes post-D7 of induction.
3.6. Gene expression proﬁle reveals expression patterns characterising dif-
ferent stages of adipocyte differentiation in ASCs
Analysis of gene expression patterns during adipogenesis revealed
that the levels of known general adipogenic differentiation marker
genes such as FABP4, ADIPOQ, LPL, and PLIN1 increased during
adipogenic differentiation (D7–D21),which is in accordancewith previ-
ous reports (Ullah et al., 2013). This implies that genes that were signif-
icantly up-regulated only from D7 to 21 will most likely also serve as
potential general adipogenic differentiation markers (Fig. 5). The in-
crease in fold change of known adipogenic differentiation markers
with ASC differentiation indicates that the cell culture system used in
this study represents a fully functional system to study adipogenesis
in vitro. Furthermore, genes with increasing fold change in a differenti-
ation dependent manner may play an increasingly important role in
driving the differentiation process in ASCs forward. From the 61 genes
signiﬁcantly up-regulated within 24 h of induction of adipogenesis,
ﬁve, namely CCDC69, PER1, REV3L, SLC7A8 and TMEM158were uniquely
up-regulated up to D7 and thereafter dropped below the cut-off point
(FC ≥ 4) (Fig. 6A). Studies have shown that knock down of PER1 in 3T3
ﬁbroblasts, 3T3-L1 preadipocytes, and MMH-D3 hepatocytes gives rise
to a cell type-speciﬁc clock phenotype and also shows strong behav-
ioral effects in knockout mice (Ramanathan et al., 2014). It will
therefore be important to investigate the role played by the early ex-
pression of this circadian clock gene in the process of adipogenic dif-
ferentiation in ASCs. The role of SLC7A8, CCDC69 and TMEM158 in
adipogenesis has not been well described and requires functional
studies to establish their role in preadipocyte differentiation. Over-
all, these ﬁve genes that were signiﬁcantly expressed only up to
7 days of differentiation may play an important role in deﬁning
the initial steps in adipogenesis and could therefore serve as poten-
tial early adipogenic differentiation markers in preadipocytes
(genes expressed by preadipocytes primed towards adipogenic
differentiation).
We identiﬁed 33 genes (ACSF2, AOC2, C7, CEBPA, CFD, CLMN, CNTFR,
COL4A1, COL4A2, COMP, CRLF1, CYP7B1, DUSP4, F3, FBN2, GYG2, KLB,
LIPE, MLXIPL, MMP3, OLFM2, PCDH9, PCK1, PNPLA2, PNPLA3, PPARG,
PPP1R1A, RORB, SLC38A4, SMOC2, SORBS1; KIAA0894, TUSC5 and
ZNF117) that were signiﬁcantly up-regulated speciﬁcally on D14 and
D21 (Fig. 6B) coinciding with the adipocyte maturation phase. Some
of these genes, which include CEBPA and PPARG, are known to be
Fig. 5. Possiblemarkers characterising adipocyte differentiation in ASCs. Gene expression patterns during adipogenic differentiation in ASCs reveal the possiblemarker genes indicative of
different stages in adipogenesis. Genes in bold represent well characterised genes for the different stages in adipogenesis.
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serve as potential late stage adipogenic differentiation markers (genes
expressed by terminally differentiated andmature adipocytes) and pos-
sibly markers representing a characteristic phenotype of a matureFig. 6. Expression proﬁle for early and late stage markers of adipocyte differentiation. The early
their expression drops signiﬁcantly after D7 (A),while the late stage genes are expressed inASCs
line at 4-fold change represents the fold change threshold used in this study. The value plotted
computed by TAC using unpaired One-Way Analysis of Variance (ANOVA) at p b 0.05 and Benadipocyte. Of these 33 genes, AOC2, CNTFR, COMP, F3, FBN2, GYG2, KLB,
PCDH9, PPP1R1A and SLC38A4 encode functional proteins, whose role
in adipogenesis has not yet been well described. The late expression
(D14 and D21) of these 10 genes during this adipogenic time-coursestage marker genes are expressed in ASCs immediately upon adipogenic stimulation and
only fromD14 representing terminally differentiated andmatureASCs (B). The horizontal
for each gene is the average fold change value obtained for the four biological replicates
jamini–Hochberg Step-Up FDR p-value b 0.5.
Fig. 7. RT-qPCR validation of gene expression proﬁles obtained by microarray. RT-qPCR data of genes representing general, early and late stage differentiation showed similar trends in
gene expression proﬁle to those obtained by microarray. Expression values plotted were mean and SEM for four biological replicates.
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733M.A. Ambele et al. / Stem Cell Research 16 (2016) 725–734differentiation study suggests that they may be actively involved in ad-
ipocyte maturation, lipid formation, accumulation and metabolic pro-
cesses or size determination of mature adipocytes. This remains to be
tested in functional studies.
We validated gene expression using RT-qPCR for some of the genes
representing general adipocyte differentiation markers as well as
genes characterised from the microarray experiments in this study
representing early and late stage differentiation. Similar pattern in
gene expression proﬁles was observed using RT-qPCR and the microar-
ray gene expression data, and this is shown in Fig. 7.
3.7. Relevant canonical pathways and molecular networks in ASCs during
adipogenic differentiation
Molecular network analysis using QIAGEN's Ingenuity® Pathway
Analysis (IPA) software showed that HSD11B1, ZBTB16, FOXO1, LMO3,
WNT5A, IRS2, RGS2, FRZB, IGF1, LGALS12, PIK3R1, SFRP1, ADIPOQ, FABP4,
MMP3, PPARG, CEBPA and PPARGC1A are up-regulated and are involved
in adipocyte differentiation on different days with HSD11B1, ZBTB16,
FOXO1, LMO3, andWNT5A being signiﬁcantly up-regulated from D1 to
D21. The observed increase in the expression ofWNT5A during adipo-
cyte differentiation was inconsistent with the IPA prediction, which re-
ported that human WNT5A decreases with adipocyte differentiation.
Molecular network analysis revealed that adipocyte differentiation is
linked to other functional and disease processes such as cell movement
and migration of leukocytes, cancer and cardiovascular disease. This is
due to genes that are shared amongst their networks and that are also
involved in adipocyte differentiation. ZBTB16, FOXO1, WNT5A, IRS2,
IGF1, PIK3R1, SFRP1, AIPOQ, FABP4, PPARG, CEBPA, CNR1, NPR1, CES1,
CD36, AOC3,MCAM, ANGPT, F3, C6 and HP are up-regulated and are in-
volved in cell movement and leukocyte migration. LGALS12, FOXO1,
WNT5A, MMP3, IGF1, SFRP1, ADIPOQ, FASN, GPC3, IL1RL1, TIMP4, PRL,
APCDD1 andMCAM are up-regulated and are involved in the activation
of different cancer related processes like tumor growth (benign andma-
lignant) including mammary tumor growth, and tumor cell invasion
and metastasis. HSD11B1, FABP4, ADIPOQ, IGF1, EDNRB, IL1R1, CD36,
ACAT2, LPL and CORIN are involved in the activation of different CVD re-
lated processes such as cardiac contraction, heart rate, blood pressure,
atherosclerosis and dysfunction of the heart. This data provides a poten-
tial link between adipocyte differentiation and leukocyte migration,
tumor growth, invasion and metastasis and CVD.
A comparative analysis of canonical pathways enriched for up-
regulated gene sets on D1–D21 was performed and the Fisher's exact
test was used to score the signiﬁcance of each pathway at the different
time points. This analysis revealed up-regulated genes on D1 that were
signiﬁcantly enriched for signaling pathways such as ErbB2–ErbB3,
JAK1 and JAK3 in γc cytokine signaling, VEGF and others (Table S3) sug-
gest that these pathways might play an important role in the initial
phase of adipocyte differentiation. Genes involved in PPAR signaling,
IL-17 signaling and some cancer pathways were signiﬁcantly enriched
in D21 up-regulated gene sets (Table S3), suggesting not only the im-
portance this set in the proper functioning of the mature adipocyte,
but also the possible association of these genes with disease processes
like cancer. Furthermore, up-regulated genes fromD7 to 21were signif-
icantly enriched for pathways such as T2DM, adipogenesis and PPARα/
RXRα activation. Surprisingly, only D14 up-regulated gene sets were
signiﬁcantly enriched for triacylglycerol biosynthesis metabolic path-
ways, suggesting the importance of genes expressed on D14 in deter-
mining the characteristic phenotype of mature white adipocytes, since
triglyceride is the main storage form of fat in white adipose tissue
(Dawkins and Stevens, 1966; Ahmadian et al., 2007).
Based on the calculated activation z-score in IPA, the NFAT canonical
pathway that plays a role in cardiac hypertrophywas predicted to be ac-
tivated (z-score=2) onD7 andD21,while the colorectal cancermetas-
tasis signaling pathway was predicted to be activated (z-score N 2) only
on D21.Further analysis in IPA for diseases and disorders signiﬁcantly asso-
ciated with genes up-regulated on different days revealed that genes
that were up-regulated from D1 to 21 were signiﬁcantly enriched for
certain pathophysiological conditions classiﬁed in IPA as belonging to
cancer, CVD,metabolic disease, reproductive systemdisease, nutritional
disease, gastrointestinal disease, hepatic system disease, neurological
disease, haematological disease, developmental disorders, endocrine
system disorders, connective tissue disorders, inﬂammatory disease,
skeletal andmuscular disorders, psychological disorders, hereditary dis-
orders and immunological disease. Some of the identiﬁed conditions
here have previously been reported to be obesity related such as cancer,
CVD and metabolic disease (Stephens, 2012; WHO, 2014). The enrich-
ment therefore of up-regulated gene sets representative of these patho-
physiological conditions suggests a possible association with obesity. In
addition, the up-regulated genes strongly associated with the different
pathophysiological conditions in this study might serve as potential
prognostic markers for the different obesity related conditions. Detailed
analysis of the cancer and cardiovascular signaling pathways enriched
in up-regulated gene sets on each day during adipocyte differentiation
revealed that genes associated with ovarian cancer signaling, colorectal
cancer metastasis signaling, acute myeloid leukaemia signaling, cardiac
β-adrenergic signaling and eNOS signaling pathways were signiﬁcantly
enriched on D21 only. Genes associated with prostate cancer signaling,
HER-2 signaling breast cancer and NFAT signaling in cardiac hypertro-
phy were speciﬁcally enriched only in D1 up-regulated gene sets. This
observation further supports the positive correlation between excess
adipocyte accumulation and an increased risk of developing cancer
and CVD (Stephens, 2012; WHO, 2014). In addition, IPA predicted
genes that were up-regulated on D21 formed a functional interacting
network identiﬁed as being operative in cellular movement, nervous
system development and function and cancer. Similarly, interactions
among D14 up-regulated genes formed an interactive network identi-
ﬁed to be operative in cardiovascular disease, cancer, organismal injury
and abnormalities. This suggests that genes up-regulated during
adipogenic differentiation play an important functional role in interac-
tive networks that occur in different biological processes and reveals
their potential link to some of the obesity-related diseases like cancer
and CVDs.
4. Conclusions
Herewe report a comprehensive and unique transcriptomic study of
the kinetics of gene expression duringASC adipogenesis in vitro. Despite
the limitation of the study design including the use of relatively late pas-
sage ASCs and the lack of BMI measurements for all four donors, the
study nonetheless identiﬁed genes that could potentially be used to dis-
tinguish adipocytes at the early (SLC7A8 and TMEM158) and late
(COL4A1, PCK1, RORB, CEBPA and PPARG) stages of differentiation,
while others (FABP4, PLIN1, ADIPOQ, AOC3, IGF1, ACSL5 and APCDD1)
were identiﬁed to be general adipocyte markers. ASCs were also found
to express unique gene signatures on different days during in vitro adi-
pogenesis. The identiﬁcation of FOXO1 and its functional interacting
partners such as SIRT1, whose role in adipogenesis has been well de-
scribed in US patent US20050136429 A1 (Guarente and Picard, 2005),
validates our hypothesis and the methodology that could be used to
identify potential anti-obesity therapeutic targets. The identiﬁcation of
MED1, EP300 and NCOA1 as functional partners interacting strongly
with the anti-diabetic thiazolidinedione (TZD) drug target PPARG
(Lehrke and Lazar, 2005)warrants further investigation in vivo to estab-
lish their suitability as potential drug targets in combating obesity and
its associated diseases. PER1 and RORB are two important circadian
clock genes identiﬁed in this study, which could play a role in control-
ling the internal circadian clock driving adipogenesis/adipocyte forma-
tion.MLXIPL and ZNF117 TFs, which have not previously been reported
to play a role in adipogenesis, were identiﬁed to be signiﬁcantly up-
regulated from D14 onwards. Functional studies of these TFs will
734 M.A. Ambele et al. / Stem Cell Research 16 (2016) 725–734provide greater insight into their role in adipogenesis and might serve
as potential targets for regulating this process. Functional network anal-
ysis revealed that ASC adipogenesis leads to signiﬁcant enrichment of
genes associatedwith different pathophysiological conditions including
various cancers and cardiovascular signaling pathways. For example,
adipocyte maturation correlates with the activation of colorectal cancer
metastasis signaling, strengthening the link between obesity and the
risk of cancer development. Overall, this study provides a unique re-
source formany functional studies of geneswith no previously reported
role in adipogenesis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.04.011.
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